Cryoport, Inc. CYRX R2K
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Excellent profit margin of 43.6%.
- Profit CAGR of 103.2% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -9.4% CAGR over 5 years.
- RSI at 81 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CYRX Cryoport, Inc. R2K | 15.69 | - | $790.81M | - | -5.46% | -8.20% | -9.45% | 103.25% |
| 2 | CAT Caterpillar Inc. SPX | 875.87 | 43.66 | $403.42B | 0.69% | 19.42% | 51.33% | 4.38% | 9.83% |
| 3 | GE GE Aerospace SPX | 323.76 | 40.17 | $338.27B | 0.58% | 11.89% | 45.43% | 16.32% | 195.89% |
| 4 | GEV GE Vernova Inc. SPXAI | 968.32 | 28.33 | $260.21B | 0.21% | 6.30% | 75.71% | 8.68% | 92.84% |
| 5 | RTX RTX Corporation SPX | 179.66 | 33.64 | $241.95B | 1.54% | 9.41% | 11.57% | 9.72% | 9.01% |
| 6 | UNP Union Pacific Corporation SPX | 262.64 | 21.60 | $155.93B | 2.10% | 16.19% | 40.69% | -0.49% | 0.66% |
| 7 | ETN Eaton Corporation plc SPXAI | 400.60 | 39.20 | $155.55B | 1.10% | 16.23% | 20.84% | 9.77% | 18.41% |
| 8 | HON Honeywell International Inc. NDXSPX | 237.86 | 38.00 | $150.72B | 2.00% | 13.57% | 24.26% | 1.82% | -1.62% |
| 9 | DE Deere & Company SPX | 542.18 | 30.67 | $146.45B | 1.20% | 12.82% | 18.35% | -4.50% | -11.00% |
Quarterly Results
Figures in USD.
| Metric | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 37.29M | 39.71M | - | - | 41.04M | 45.45M | 44.23M | 45.45M | 47.80M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.40M | 24.08M | 22.91M | 23.74M | 25.89M |
| Gross Profit | 0 | 782.00K | 797.00K | 941.00K | 1.25M | 1.39M | 1.61M | 1.71M | 2.18M | 2.50M | 2.74M | 2.82M | 3.45M | 4.34M | 4.63M | 4.93M | 5.26M | 5.13M | 6.05M | 19.89M | 24.55M | 25.40M | 23.51M | 23.11M | 22.34M | 28.84M | 26.42M | 26.28M | 27.07M | 24.73M | 24.27M | 15.06M | 17.66M | - | - | 18.64M | 21.38M | 21.32M | 21.71M | 21.91M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.84M | 31.03M | 31.26M | 31.74M | 31.53M |
| Operating Income | 0 | -1.98M | -2.16M | -2.00M | -1.77M | -1.86M | -1.99M | -2.27M | -1.80M | -2.46M | -2.16M | -2.22M | -2.14M | -2.30M | -12.35M | -878.00K | -3.59M | -5.84M | -10.73M | -9.85M | -1.14M | -3.75M | -4.58M | -8.36M | -7.82M | -5.25M | -7.80M | -11.04M | -10.04M | -18.33M | -16.91M | -17.51M | -78.03M | - | - | -7.19M | -9.65M | -9.93M | -10.03M | -9.61M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.73M | -3.83M | 410.00K | -406.00K | -2.49M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 583.00K | 618.00K | 526.00K | 634.00K | 432.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.50M | -11.74M | -6.53M | -7.39M | -9.32M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 234.00K | 274.00K | 165.00K | 1.13M | 108.00K |
| Net Income | 0 | -3.94M | -2.18M | -4.28M | -1.79M | -1.86M | -1.98M | -2.27M | -2.68M | -2.47M | -2.14M | -2.26M | -2.39M | -2.53M | -12.47M | -948.00K | -3.94M | -5.80M | -11.42M | - | -3.53M | -5.39M | -6.53M | - | -13.40M | -9.18M | -5.32M | - | -5.57M | -18.36M | -13.27M | -18.89M | -77.99M | - | - | -11.98M | 105.18M | -6.94M | -11.64M | -10.54M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.11 | -0.15 | -0.29 | -1.32 | -0.13 | -0.16 | -0.18 | -5.46 | -0.31 | -0.23 | -0.15 | -0.24 | -0.16 | -0.42 | -0.31 | -0.43 | -1.62 | - | - | -0.28 | 2.05 | -0.18 | -0.27 | -0.25 |
| R&D Expense | 144.48K | 135.80K | 214.68K | - | 249.84K | 230.74K | 344.80K | - | 329.73K | 448.59K | 463.36K | - | 489.60K | 540.93K | 1.64M | - | 1.73M | 1.95M | 2.31M | - | 4.30M | 4.46M | 4.19M | - | 3.54M | 3.52M | 3.98M | - | 3.88M | 4.26M | 5.15M | 4.75M | 4.65M | 4.16M | - | 3.93M | 4.12M | 4.52M | - | 3.91M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 237.28M | 168.66M | 156.77M | 176.18M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 133.40M | 93.33M | 87.11M | 93.12M |
| Gross Profit | -827.48K | -836.82K | -487.28K | 436.95K | 1.17M | 1.89M | 3.10M | 5.97M | 10.24M | 17.35M | 36.33M | - | 103.87M | 75.33M | 69.66M | 83.05M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 135.78M | 126.30M | 127.52M | 119.86M |
| Operating Income | -5.60M | -7.43M | -6.32M | -5.08M | -5.59M | -8.74M | -8.77M | -7.89M | -8.64M | -17.68M | -30.01M | - | -31.90M | -50.97M | -57.86M | -36.81M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | -6.19M | -51.15M | -69.61M | -2.10M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | 6.14M | 5.58M | 3.98M | 2.36M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -35.09M | -84.21M | -104.35M | -32.17M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 2.24M | 345.00K | 359.00K | 1.80M |
| Net Income | -6.15M | -7.83M | -6.38M | -19.57M | -7.03M | -9.82M | -13.11M | -7.90M | -9.56M | -18.33M | -32.69M | - | -37.33M | -99.59M | -114.76M | 78.30M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | -0.55 | -1.94 | - | -0.93 | -2.21 | -2.49 | 1.40 |
| R&D Expense | 449.13K | 491.85K | 425.45K | 409.11K | 352.58K | 550.26K | 598.11K | 1.21M | 1.84M | 3.74M | 9.48M | 16.84M | 15.72M | 18.04M | 17.71M | 17.04M |
Compounded Sales Growth
| 5 Years: | -9.45% |
| 1 Year: | 16.50% |
Compounded Profit Growth
| 5 Years: | 103.25% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +161.06% |
| 6 Months: | +61.92% |
| 3 Months: | +86.34% |
| 1 Month: | +60.10% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Dec 2015 | Mar 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 11.03M | 6.21M | 1.76M | 1.71M | 2.61M | - | 5.82M | 8.11M | 20.26M | 56.62M | 135.87M | 552.40M | - | 1.04B | 957.74M | 703.49M | 764.99M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 604.18M | 535.11M | 341.57M | 476.17M |
| Cash & Equivalents | 3.63M | 9.28M | 4.62M | 563.10K | 369.58K | 1.41M | 5.25M | 2.79M | 4.52M | 15.04M | 37.33M | 47.23M | 36.87M | - | 36.59M | 46.35M | 34.14M | 250.49M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 27.68M | 26.21M | 21.48M | 23.19M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.86M | 42.07M | 25.30M | 33.36M |
| Total Liabilities | - | 5.08M | 2.48M | 3.82M | 4.01M | 3.02M | - | 2.73M | 2.43M | 2.38M | 18.07M | 9.59M | 169.71M | - | 482.91M | 468.72M | 301.59M | 262.35M |
| Current Liabilities | - | 3.24M | 1.11M | 2.50M | 4.01M | 3.00M | - | 2.17M | 2.23M | 2.20M | 3.06M | 5.46M | 35.02M | - | 40.85M | 45.61M | 64.56M | 219.02M |
| Long Term Debt | - | - | 325.32K | 1.29M | - | - | - | - | - | - | - | - | - | - | 407.06M | 379.89M | 185.03M | 1.09M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 435.91M | 416.00M | 242.54M | 230.72M |
| Total Equity | -914.58K | 5.95M | 3.73M | -2.06M | -2.30M | -416.30K | - | 3.10M | 5.68M | 17.89M | 38.55M | 126.28M | 382.70M | - | 555.84M | 489.02M | 401.90M | 502.64M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 48.33M | 48.97M | 49.91M | 49.85M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.81M | -6.78M | -4.79M | - | - | - | -5.72M | -3.58M | -3.35M | -1.32M | -14.87M | - | -1.85M | -757.00K | -16.32M | -8.58M |
| Investing Cash Flow | -465.45K | -388.06K | -178.68K | - | - | - | -1.07M | -1.80M | -12.88M | -62.93M | -382.31M | - | -59.68M | 36.05M | 176.81M | 250.32M |
| Financing Cash Flow | 10.93M | 2.51M | 909.39K | - | - | - | 6.06M | 15.90M | 38.53M | 74.15M | 385.58M | - | -39.17M | -23.80M | -161.53M | -21.07M |
| Capital Expenditure | -341.40K | -262.64K | -156.20K | -138.89K | -70.13K | -1.12M | -1.06M | -1.71M | -2.91M | -5.34M | -8.92M | - | -24.20M | -44.90M | -21.27M | -19.50M |
| Free Cash Flow | -5.15M | -7.04M | -4.94M | - | - | - | -6.78M | -5.30M | -6.27M | -6.66M | -23.78M | - | -26.05M | -45.66M | -37.59M | -28.09M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | -100.71M | 11.49M | -1.04M | 220.67M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 37.96M | - | - | 10.01M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | 43.8% | 44.7% | 44.4% | 47.1% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -13.4% | -30.2% | -36.9% | -20.9% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -15.7% | -59.0% | -73.2% | 44.4% |
| ROE % | -103.4% | -210.0% | 309.3% | 849.0% | 1,687.9% | -317.2% | -230.9% | -44.2% | -24.8% | -14.5% | -8.5% | - | -6.7% | -20.4% | -28.6% | 15.6% |
| ROCE % | -71.8% | -145.6% | 852.8% | 220.4% | 1,434.7% | -239.5% | -149.1% | -43.7% | -16.1% | -13.6% | -5.8% | - | -3.2% | -5.6% | -9.1% | -6.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Cadian Capital Management, LP | 9.48% | 4.78M | $74.94M |
| 2 | Morgan Stanley | 9.08% | 4.58M | $71.81M |
| 3 | Blackrock Inc. | 7.90% | 3.98M | $62.46M |
| 4 | Millennium Management Llc | 5.89% | 2.97M | $46.61M |
| 5 | Vanguard Capital Management LLC | 4.20% | 2.12M | $33.24M |
| 6 | Fred Alger Management, LLC | 3.37% | 1.70M | $26.66M |
| 7 | Assenagon Asset Management S.A. | 2.97% | 1.50M | $23.47M |
| 8 | MAK Capital One LLC | 2.82% | 1.42M | $22.33M |
| 9 | Geode Capital Management, LLC | 2.48% | 1.25M | $19.58M |
| 10 | Mirova | 2.30% | 1.16M | $18.17M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CYRX